Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01208987 · ClinicalTrials.gov registry record · NA
Improving Laboratory Follow-up by Delivering an Enhanced Medication List to Outpatient Physician Practices
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 5,256
- Enrollment target
NCT01208987: Completed NA study, sponsored by Indiana University.
NCT01208987 is a NA study that has completed, run by Indiana University. The registered enrollment target is 5,256 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (274% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01208987, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,256 participants
- Enrollment target
Study Summary
The investigators plan to develop a process to create an Enhanced Medication List. The INPC (Indiana Network for Patient Care) already obtains histories of medications dispensed by pharmacies from several sources: pharmacy benefit managers, RxHub, insurance companies, Medicaid, SureScripts, Wishard Health Services. The investigators will collect all the medication data available through the INPC for an individual patient. The investigators will enhance this medication list by including medication categories, improving the structure and appearance, displaying results of relevant laboratory tests, and adding decision support reminders. The investigators will test the value of such an "Enhanced Medication List" by providing it to outpatient physician practices (through the DOCS4DOCS clinical messaging service, or as a fax), preferably on the day that the patient has an office visit with the physician. The investigators will determine whether this intervention improves patient care: whether there are higher rates of recommended laboratory follow-up monitoring as a result; whether there are lower rates of harmful drug-drug interactions. The investigators will also seek the opinions of physicians regarding the benefit of this intervention.
Primary Outcome
The hypothesis is that the intervention (a medication history printed for the patient) would help the physician identify incomplete monitoring of laboratory test results for a subset of medications. (For example, Potassium test levels should be obtained every 12 months for patients using diuretics, according to NCQA HEDIS guidelines.) With time, the intervention group should have less medications for which laboratory test results are incomplete. Therefore, the intervention group should have less
Interventions
- OTHER Medication History was printed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,256 participants |
| Start Date | 2007-09-28 |
| Est. Completion | 2011-10-01 |
| Phase | NA |
What the finished NCT01208987 record still lists
NCT01208987 is an interventional study that assigns participants to a tested intervention. Its 5,256 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (274% higher).
The record links to 0 conditions, and to 1 intervention - of which Medication History was printed is the first listed.
NCT01208987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01208987 about?
NCT01208987 is a clinical study titled "Improving Laboratory Follow-up by Delivering an Enhanced Medication List to Outpatient Physician Practices". The investigators plan to develop a process to create an Enhanced Medication List. The INPC (Indiana Network for Patient Care) already obtains histories of medications dispensed by pharmacies from several sources: pharmacy benefit managers, RxHub, insurance companies, Medicaid, SureScripts, Wishard ...
What is the current status of trial NCT01208987?
This trial is currently completed. It is a NA study. The enrollment target is 5,256 participants. The study started on 2007-09-28. Estimated completion is 2011-10-01.
What interventions are being tested in trial NCT01208987?
The interventions under investigation include: Medication History was printed (OTHER).
Who is sponsoring clinical trial NCT01208987?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01208987's enrollment target sits among peer trials
5,256 24th of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI